Detalhe da pesquisa
1.
Redefining ß-blocker response in heart failure patients with sinus rhythm and atrial fibrillation: a machine learning cluster analysis.
Lancet
; 398(10309): 1427-1435, 2021 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34474011
2.
Effect of Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement on All-Cause Mortality in Patients With Aortic Stenosis: A Randomized Clinical Trial.
JAMA
; 327(19): 1875-1887, 2022 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579641
3.
B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease.
BMC Med
; 17(1): 72, 2019 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30943979
4.
Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials.
Eur Heart J
; 39(1): 26-35, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29040525
5.
Darapladib for preventing ischemic events in stable coronary heart disease.
N Engl J Med
; 370(18): 1702-11, 2014 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24678955
6.
The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study.
Eur Heart J
; 36(6): 377-84, 2015 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25079365
7.
Efficacy of ß blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.
Lancet
; 384(9961): 2235-43, 2014 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25193873
8.
Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration.
Am Heart J
; 169(5): 605-12, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25965707
9.
The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study.
Circulation
; 128(3): 237-43, 2013 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-23770747
10.
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study.
Eur Heart J
; 33(17): 2143-50, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22450429
11.
Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of ThrombinCoronary Artery Disease Trial.
Circulation
; 123(17): 1854-63, 2011 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21502571
12.
Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of ThrombinAcute Coronary Syndromes Trial.
Circulation
; 123(17): 1843-53, 2011 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21502577
13.
Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program.
J Thromb Thrombolysis
; 34(1): 36-43, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22653705
14.
Very early invasive angiography versus standard of care in higher-risk non-ST elevation myocardial infarction: study protocol for the prospective multicentre randomised controlled RAPID N-STEMI trial.
BMJ Open
; 12(5): e055878, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35504645
15.
ß blockers in patients with heart failure and atrial fibrillation - Authors' reply.
Lancet
; 385(9978): 1618-9, 2015 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25943812
16.
Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials.
Am Heart J
; 161(5): 822-831.e2, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21570510
17.
Cluster-randomized trial to evaluate the effects of a quality improvement program on management of non-ST-elevation acute coronary syndromes: The European Quality Improvement Programme for Acute Coronary Syndromes (EQUIP-ACS).
Am Heart J
; 162(4): 700-707.e1, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21982663
18.
Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease.
Eur Heart J
; 31(21): 2601-13, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20805115
19.
Change in serum lipids after acute coronary syndromes: secondary analysis of SPACE ROCKET study data and a comparative literature review.
Clin Chem
; 56(10): 1592-8, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20729301
20.
Role of dual antiplatelet therapy in symptomatic patients with established vascular disease: putting the CHARISMA trial into therapeutic perspective.
Cardiovasc Drugs Ther
; 24(3): 207-16, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20593231